The Capital Group

FAST NEWS: U.S. investment firm boosts WuXi AppTec stake

The latest: The Capital Group, a U.S. asset manager, disclosed it purchase 2.52 million Hong Kong-listed shares of WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) for HK$177 million ($20.8 million), raising…
2359.HK 603259.SHG

Recent Articles

RELATED ARTICLES

  1. WuXi Biologics
    WuXi Biologics sells vaccine plant as new U.S. law looms
    2269.HK
  2. BRIEF: WuXi AppTec sells advanced therapies units in U.K. and U.S.
    2359.HK 603259.SHG
  3. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  4. Cancer drug maker Genfleet joins Hong Kong IPO influx
  5. Innovent ditches low-value stake sale after investor outcry
    1801.HK
  6. Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva